Dr. Khorana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-444-6833Fax+1 216-444-9423
Summary
- Alok A. Khorana, M.D., F.A.C.P, F.A.S.C.O, is Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, the Sondra and Stephen Hardis Chair in Oncology Research, Vice-Chair for Clinical Services of the Taussig Cancer Institute (part of Case Comprehensive Cancer Center) and Director of the Gastrointestinal Malignancies Program at the Cleveland Clinic, Cleveland, Ohio. His clinical and translational research program focuses on predictive factors and drug development in cancer-associated thrombosis and gastrointestinal cancers and has been funded by grants from the National Cancer Institute, the National Heart, Lung, and Blood Institute, the Hardis Family, the Porter Family Fund, VeloSano, the Cleveland Clinic Center for Excellence, the Scott Hamilton CARES Initiative, Stand Up To Cancer (Colorectal Cancer “Dream Team”) and the V Foundation.
Dr. Khorana received his medical degree from Maharaja Sayajirao University’s Medical College in Baroda (now Vadodara, Gujarat), India. His postdoctoral training included a residency in internal medicine at the University at Buffalo in New York and a fellowship in hematology/oncology at the University of Rochester, New York. He is a Fellow of the American College of Physicians and in 2018 was elected Fellow of the American Society of Clinical Oncology.
Dr. Khorana is Past Chair of the American Society of Clinical Oncology (ASCO) Clinical Practice Guidelines Panel (CPGC), Chair of ASCO CPGC’s Pancreas Cancer Working Group, Co-Chair of ASCO CPGC’s Multisite Advisory Group and Co-Chair of the ASCO Guidelines Panel on Resectable Pancreas Cancer. He is currently Chair of the Medical and Scientific Advisory Board of the National Blood Clot Association. He has also served or serves on the ASCO Scientific Program Committee and multiple Guidelines/Guidance Panels.
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 1999 - 2002
- University at BuffaloResidency, Internal Medicine, 1996 - 1999
- Baroda Medical CollegeClass of 1995
Certifications & Licensure
- OH State Medical License 2013 - 2026
- NY State Medical License 2002 - 2014
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Maria and Sam Miller Professional Excellence Award for Scientific Achievement in Clinical Research Cleveland Clinic, 2019
- Teacher of the Year (Medical Oncology) Cleveland Clinic, 2018
- Meliora Award (Team Award( University of Rochester, 2013
- Join now to see all
Clinical Trials
- Cancer Associated Thrombosis and Isoquercetin (CATIQ) Start of enrollment: 2015 Jan 01
- CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer Start of enrollment: 2016 Sep 12
Publications & Presentations
PubMed
- Is Early, Postinduction Restaging of Rectal Cancer Undergoing Total Neoadjuvant Therapy Associated With Ultimate Treatment Response?William C Chapman Jr, Emre Gorgun, Sumeyye Yilmaz, David R Rosen, Michael A Valente
Diseases of the Colon and Rectum. 2025-02-01 - What Predicts Complete Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer?Sumeyye Yilmaz, David Liska, Madison L Conces, Naz Tursun, Doua Elamin
Diseases of the Colon and Rectum. 2025-01-01 - Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.Jordan M Cloyd, Angela Sarna, Matthew J Arango, Susan E Bates, Manoop S Bhutani
JAMA Surgery. 2024-12-04
Journal Articles
- Do Patients with Pancreatic Body or Tail Cancer Benefit from Adjuvant Therapy?A Cohort StudyAlok Khorana, MD, ScienceDirect
- An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity indexBewtra Meenakshi, Brensinger Colleen M, Tomov Vesselin T, Hoang Tram B, Sokach Carly E, Siegel Corey A, Lewis James D, Inflammatory Bowel Diseases, 6/1/2014
- Diagnosis of Dry Eye Disease and Emerging TechnologiesZeev MS, Miller DD, Latkany R, Clin Opthalmol, 3/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Molecular Subtyping to Predict Risk of Venous Thromboembolism in Patients with Advanced Lung Adenocarcinoma: A Cohort StudyAlok A Khorana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated ThrombosisAlok A Khorana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of AnticoagulationAlok A Khorana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Cancer Associated Thrombosis Is Associated with Higher Mortality across All Khorana Score Risk Levels61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- What's New in VTE? Evaluating the Latest Evidence and Grades of Recommendation60th American Society of Hematology Annual Meeting - 11/30/2018
- Generosity: Normal and PathologicalWeill Cornell Medical School, New York, NY - 10/15/2014
- Join now to see all
Press Mentions
- Cleveland Clinic Research Reveals Unique Tumor-Related Bacteria Tied to Young-Onset Colorectal CancerFebruary 5th, 2024
- ‘I’m Terminal’ at 60: Why Are Colorectal Cancer Patients Getting Younger?March 1st, 2023
- Blood Test Could Help Predict Which Patients with Colon Cancer Need Chemotherapy After Surgery: StudyJanuary 17th, 2023
- Join now to see all
Grant Support
- Risk Factors For Venous Thromboembolism In Cancer Patients Receiving ChemotherapyNational Cancer Institute2006–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: